Clover Health Investments, Corp. logo

Clover Health Investments, Corp. (7QD)

Market Open
15 Oct, 06:09 AM
XMUN XMUN
€
4. 30
-0.01
-0.232%
€
1.65B Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
€ 4.31
Previous Close
Add Transaction
Day Range
4.3 4.3
Year Range
1.49 4.7
Want to track 7QD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

7QD trading today lower at €4.3, a decrease of -0.232% from yesterday's close, completing a monthly increase of 11.1111% or €0.43. Over the past 12 months, 7QD stock gained 112.0316%.
7QD is not paying dividends to its shareholders.
The last earnings report, released on May 12, 2026, missed the consensus estimates by -0.0329%. On average, the company has fell short of earnings expectations by -0.0021%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).

7QD Chart

People also search for

L97
Yonghe Medical Group Co., Ltd.
€ 0.23
0%
WEK
ZIOPHARM Oncology, Inc.
€ 149.25
0%
Clover Health Sees PPO Edge, Cohort Gains as Medicare Advantage Pricing Tightens

Clover Health Sees PPO Edge, Cohort Gains as Medicare Advantage Pricing Tightens

Clover Health Investments NASDAQ: CLOV is positioning its Medicare Advantage business to benefit from industry pricing discipline, member retention and the maturation of member cohorts, Interim Chief Financial Officer Clay Thornton said at Jefferies' Healthcare Services and Technology Conference in Nashville.

Marketbeat | 3 weeks ago
Clover Health Is A 'Buy' Because Of Its AI

Clover Health Is A 'Buy' Because Of Its AI

Clover Health Investments, Corp. leverages its AI-powered Clover Assistant to drive lower claims costs and improve member profitability. Baseline and bullish DCF valuations yield fair values of $5.02 and $14.10 per share, respectively, versus the current $4.15 price. Key upside drivers include rapid membership growth, AI-enabled cost savings, and a potential $120M Medicare Advantage bonus tied to a 4.5-star CMS rating.

Seekingalpha | 1 month ago
Clover Health Investments: Real Turnaround, But Already Priced In

Clover Health Investments: Real Turnaround, But Already Priced In

Clover Health Investments (CLOV) is rated Hold, with operational execution but a cautious outlook due to valuation and litigation risks. CLOV's Medicare Advantage membership grew 48% YoY, revenue and GAAP net income improved, but profitability per member lags FY2024 levels. FY2026 guidance implies negative H2 results; $120M in quality bonus revenue is at risk pending CMS litigation outcome.

Seekingalpha | 2 months ago

Clover Health Investments, Corp. (7QD) FAQ

What is the stock price today?

The current price is €4.30.

On which exchange is it traded?

Clover Health Investments, Corp. is listed on XMUN.

What is its stock symbol?

The ticker symbol is 7QD.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 1.65B.

Has Clover Health Investments, Corp. ever had a stock split?

No, there has never been a stock split.

Clover Health Investments, Corp. Profile

Health Care Providers & Services Industry
Healthcare Sector
Andrew Toy CEO
XMUN Exchange
US18914F1030 ISIN
US Country
724 Employees
23 Aug 2021 Last Dividend
- Last Split
- IPO Date

Overview

Clover Health Investments, Corp., headquartered in Franklin, Tennessee, is a healthcare company that specializes in providing Medicare Advantage plans across the United States. The company operates two main segments: Insurance and Non-Insurance, targeting to enhance the healthcare experience for Medicare beneficiaries through tech-driven solutions and data analysis. By focusing on predictive healthcare and proactive management of chronic diseases, Clover Health aims to improve patient outcomes while controlling costs.

Products and Services

  • Medicare Advantage Plans:

    As its core offering, Clover Health Investments, Corp. delivers Medicare Advantage plans designed to meet the diverse needs of Medicare beneficiaries. These plans are structured to provide more benefits than traditional Medicare, including prescription drug coverage, preventive care, and access to a broad network of healthcare professionals.

  • Clover Assistant:

    This innovative, cloud-based software platform is a key differentiator for Clover Health. The Clover Assistant facilitates data-driven and personalized healthcare by enabling physicians to detect, identify, and manage chronic conditions more effectively and earlier in their progression. By providing access to comprehensive, real-time health data and insights about their patients, Clover Assistant empowers healthcare providers to make informed decisions that enhance patient care and outcomes.

Contact Information

Address: 1209 Orange Street
Phone: 201 432 2133